https://pipelinereview.com/Samsung-Bioepis-Obtains-First-Drug-Approval-in-the-United-States-as-the-U.S.-Food-and-Drug-Administration-Approves-RENFLEXIS-Infliximab-abda-Across-All-Eligible-Indications/